SY. NO: PARTS OF 318, 319 AND 321 LOCATED AT –...
Transcript of SY. NO: PARTS OF 318, 319 AND 321 LOCATED AT –...
PRE - FEASIBILITY REPORT
For
PROPOSED BULK DRUGS INTERMEDIATES
MANUFACTURING UNIT
at
SY. NO: PARTS OF 318, 319 AND 321 LOCATED AT –
PALLEPAHAD VILLAGE, THURKAPALLY MANDAL,
YADADRI - BHONGIR DISTRICT, TELANGANA STATE
By
VEDGIR LIFE SCIENCES
HOUSE NO: 8-3-228/662/A, RAHAMATH NAGAR, YOUSUFGUDA, HYDERABAD
TELANGANA STATE
Contents
S. No. Description Page no.
1.0 Executive Summary 1
2.0 Introduction of The Proposed Project 2
2.1 Project Proponent 2
2.2 Brief description of nature of the project. 2
2.3 Need for the project and its importance to the country and
or region 2
2.4 Demand-Supply Gap. 4
2.5 Employment Generation(Direct and Indirect) due to the project
4
3.0 Project description 5
3.1 Product and Production Capacity 8
3.2 Raw materials required and Quantities 9
3.3 Manufacturing Process 9
3.4 Resource – Utilize and Recycling 10
3.4.1 Water 10
3.4.2 Power Requirement 10
3.4.3 Fuel Requirement 10
3.5 Quantity of wastes to be generated 10
3.5.1 Waste Water Generation and utilization 10
3.5.2 Solid waste generation and Disposal 11
3.6 Schematic representations of the feasibility drawing which give information of EIA purpose.
12
4.0 Site Analysis 12
4.1 Connectivity 12
4.2 Land Form, Land use and Land ownership. 12
4.3 Existing Infrastructure 13
4.4 Soil classification 13
4.5 Climatic data from secondary sources. 13
4.6 Social Infrastructure available. 13
5.0 Planning brief 13
6.0 Proposed infrastructure 13
6.1 Industrial Area 13
6.2 Residential Area 13
6.3 Green Belt: 14
6.4 Social Infrastructure 14
6.5 Water management 14
6.6 Sewerage System 14
6.7 Industrial Waste Management 14
7.0 Rehabilitation and Resettlement (R&R) Plan 14
8.0 Project Schedule and Cost estimates 14
9.0 Analysis of project 15
LIST OF TABLES
Table No Description Page no. 3.1 Proposed Products and Quantities 8 3.2 List of By-Products 9 3.3 Water Requirement Details 10 3.4 Wastewater generation and Treatment Method 11 3.5 Solid and hazardous waste generation and Disposal 11 & 12
LIST OF FIGURES
Figure No Description Page no. 1.1 Location Map 6 1.2 Google Earth Map Showing Clarus Chem Pvt. Ltd. 7
LIST OF FLOW CHART
Flow Chart No
Description Page no.
3.1 Generalized Flow Chart for Bulk Drug Manufacturing 9
Pre Feasibility Report
Vedgir Life Sciences Page 1
1.0 EXECUTIVE SUMMARY
Vedgir Life Sciences is a partnership firm and it is registered office at H.No.8-3-
228/662/A, Rahamath Nagar, Yousufguda, Hyderabad Telangana Sate.
S. No Parameter Description
1 Project Location
Sy No: Parts of 318,319 & 321, Pallepahad(V),
Thurkapally(M) Yadadri - Bhongiri District,
Telangana State
2 Category of Project as per EIA Notification & Amendments
5(f) “A”
3 Project cost 18 Crores
4 Plot area 9.77 Acres (39537.79 Sq.m)
5 Proposed Products Proposed Products List is mentioned in section
3.1
6 Resources
7 (I)Electricity
Requirement 800 KVA
Source of electricity Telangana State Southern Power Distribution
Company Limited (TSSPDCL)
D. G. Sets 250 KVA & 380 KVA
8 (II)Water consumption 164.15 KLD
Source of water Ground Water
Waste water generation 76.59 KLD
9 (III)Boiler 2 TPH & 5 TPH Coal Fired Boiler is Proposed
10 (IV)Fuel Coal – 28.00 MT /Day for proposed boiler Requirement
11 Mode of disposal Zero Liquid Discharge System
12 Solid waste generation Mentioned in Para 3.5.2 of report
13 Nearest Highway State Highway - 17 - (Pragnapur - Bhongir Road) – 1.90 kms (E)
14 Nearest Railway Station Bhongir Railway Station – 11.50 kms (SSE)
15 Nearest Airport Rajiv Gandhi International Airport – 58 kms
(SW)
Pre Feasibility Report
Vedgir Life Sciences Page 2
2.0 INTRODUCTION OF THE PROJECT
The objective of this pre- feasibility study is to provide information for the proposed
Bulk Drug Intermediates manufacturing unit of Vedgir Life Sciences located at Sy.
No: Parts of 318, 319 and 321 Pallepahad Village, Thurkapally Mandal, Yadadri -
Bhongir district, Telangana State.
2.1 Project Proponent
Mr. S. Mohan Reddy is Managing Partner of the company having more than 30
years experience in Pharma Industry.
2.2 Brief description of nature of the project.
Vedgir Life Sciences is proposing to manufacture Bulk Drug intermediates at Sy.
No: Parts of 318, 319 and 321 Pallepahad Village, Thurkapally Mandal, Yadadri -
Bhongir district, Telangana State.
2.3 Need for the project and its importance to the country and or region
Vedgir Life Sciences is a Greenfield project intended to start a manufacturing unit of
Bulk Drug Intermediates at Survey No: Parts of 318, 319 and 321 Pallepahad
Village, Thurkapally Mandal, Yadadri – Bhongir.
• Availability of the well-connected road and railway network for easy
transportation of the construction equipments and materials, Raw materials
and finished products.
• Easy availability of skilled and unskilled labor for construction of Plant and its
operation.
The Indian pharmaceutical industry currently tops the chart amongst India's science-
based industries with wide ranging capabilities in the complex field of drug
manufacture and technology. A highly organized sector, the Indian pharmaceutical
industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent
annually. it ranks very high amongst all the third world countries, in terms of
technology, quality and the vast range of medicines that are manufactured. It ranges
from simple headache pills to sophisticated antibiotics and complex cardiac
compounds; almost every type of medicine is now made in the Indian
pharmaceutical industry.
Pre Feasibility Report
Vedgir Life Sciences Page 3
The Indian pharmaceutical sector is highly fragmented with more than 20,000
registered units. It has expanded drastically in the last two decades. The
Pharmaceutical and Chemical industry in India is an extremely fragmented market
with severe price competition and government price control The Pharmaceutical
industry in India meets around 70% of the country's demand for bulk drugs, drug
intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals, and
injectibles. There are approximately 250 large units and about 8000 Small Scale
Units, which form the core of the pharmaceutical industry in India (including 5 Central
Public Sector Units).
The Indian pharma industry, which is expected to grow over 15 per cent per annum
between 2015 and 2020, will outperform the global pharma industry, which is set to
grow at an annual rate of 5 per cent between the same period!. The market is
expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest
pharmaceutical market globally by absolute size, as stated by Mr Arun Singh, Indian
Ambassador to the US. Branded generics dominate the pharmaceuticals market,
constituting nearly 80 per cent of the market share (in terms of revenues).
India has also maintained its lead over China in pharmaceutical exports with a year-
on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16, according to
data from the Ministry of Commerce and Industry. Imports of pharmaceutical
products rose marginally by 0.80 per cent year-on-year to US$ 1,641.15 million.
Overall drug approvals given by the US Food and Drug Administration (USFDA) to
Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-
15. The country accounts for around 30 per cent (by volume) and about 10 per cent
(value) in the US$ 70-80 billion US generics market.
2.4 Demand-Supply Gap.
There is a quite considerable gap between supply and demand for, fine chemicals,
bulk drugs and intermediates. Very few players are in the market who can offer
continuous supply. The company wants to bridge this gap between demand and
supply by expanding the production capacity and thereby, making good business.
Company's marketing edge comes from its direct and close contact with the
customers. Their products are major strength of their customers. Each stage of their
product is been monitored /checked for their quality to ensure quality product
Pre Feasibility Report
Vedgir Life Sciences Page 4
reaches their customer. They plan to launch new products every year to satisfy the
need of their customers as per the market demand.
2.5 Employment Generation (Direct and Indirect) due to the project
Approximate employment generation due to proposed unit is 70. Apart from this
there will be significant non estimated employment generation at the supplier firms
and service industry providing services to the company. Company shall be giving
preference to people from economically weaker sections for employment in various
semi-skilled/unskilled jobs thereby contributing to their upliftment.
3.0 Project Description
Vedgir Life Sciences is proposing to Manufacture Bulk Drug Intermediates with
production capacity of 75.00 TPM
The Location map is shown at Figure - 3.1 and Google earth map showing Vedgir
Life Sciences plant is shown at Figure - 3.2.
The site central GPS - coordinates are
Latitude: 17°35'49.28"N
Longitude: 78°49'7.98"E
The project site does not offer any negative impact on the local area, but rather has
a positive impact on socio economic conditions of the habitants around it because of
employment to locals.
The Vedgir Life Science is 1.90 kms away from State Highway No– 17 and 11.50
kms from Bhongir Railway Station.
Pre Feasibility Report
Vedgir Life Sciences Page 6
FIGURE 1.1: LOCATION MAP
Vedgir Life Sciences
Vedgir Life Sciences
FIGURE 1.2: GOOGLE EARTH MAP SHOWING
FIGURE 1.2: GOOGLE EARTH MAP SHOWING VEDGIR LIFE SCIENCES
Pre Feasibility Report
Page 7
VEDGIR LIFE SCIENCES.
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 8
3.1 Products, By-Products and their Production Capacities
Vedgir Life Sciences to produce below mention products with Manufacturing
Capacity of 75 TPM and the list of products are shown in Table 3.1 & 3.2.
Table 3.1: Proposed Product and Quantity
S. No Product Name Production capacity MT/
Month
1 Aceclofenac 10.00
2 Certrizine Hydrochloride 10.00
3 Domperidone 4.50
4 Drotraverine Hydrochloride 4.00
5 Emiticitabine Hydrochloride 5.00
6 Esomeprazole 3.00
7 Fexofenadine Hydrochloride 4.50
8 Fluconazole 5.00
9 Glycazide 5.00
10 Ketoconazole 5.00
11 Levetiracetam 3.00
12 Loratidine 4.00
13 Losartan Potassium 4.50
14 Lansoprazole 10.00
15 Montelukast Sodium 3.00
16 Omeprazole 10.00
17 Pantoprazole sodium 4.50
18 Sertaline Hydrochloride 5.00
19 Telmisartan 4.50
20 Tramadol Hydrochloride 10.00
Total (Worst combination of any 10 products at any given point of time)
75.00
Vedgir Life Sciences
Table 3.
S.No Name of the Product
1 Aceclofenac 2 Emtricitabine 3 Fluconazole 3 Montelukast Sodium
4 Losartan Potassium
5 Omeprazole 6 Tramadol Hydrochloride
3.2 Raw materials required and Quantities
All the raw materials required for manufacturing of above products will be sourced
from local market.
3.3 Manufacturing Process
The manufacturing process
synthesis extending to stages of processing involving different type of chemical
reactions. The generalized Flow chart for bulk drug manufacturing is shown in
chart 3.1.
Flow Chart 3.1: Generalized Flow Chart fo
PRE FEASIBILITY REPORT
Table 3.2: List of By-Products
Name of the Product Name of the By-Product
t- Butanol TEA Hcl DMSO
Montelukast Sodium Diisopropyl amine HCl
Losartan Potassium Succinimide Trityl chloride Sodium Sulphate
Tramadol Hydrochloride Magnesium Sulphate
3.2 Raw materials required and Quantities
All the raw materials required for manufacturing of above products will be sourced
3.3 Manufacturing Process
The manufacturing process of bulk drugs and Intermediates consists of chemical
synthesis extending to stages of processing involving different type of chemical
reactions. The generalized Flow chart for bulk drug manufacturing is shown in
Flow Chart 3.1: Generalized Flow Chart for Bulk Drug Manufacturing
PRE FEASIBILITY REPORT
Page 9
Quantity In Kg/Day
69.85 106.55
44.08 30.40 41.54
105.84 152.04 218.55
All the raw materials required for manufacturing of above products will be sourced
consists of chemical
synthesis extending to stages of processing involving different type of chemical
reactions. The generalized Flow chart for bulk drug manufacturing is shown in Flow
r Bulk Drug Manufacturing
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 10
3.4 Resource – Utilize & Recycling
3.4.1 Water
Water requirement of the project for domestic and industrial activity during operation
phase will be 164.15 KLD. The water requirement will be met through ground water
sources. The detailed water requirement shown in below Table 3.3.
Table 3.3: WATER REQUIREMENT DETAILS
S.No Purpose Water Input In KLD
1 Process 47.90
2 Washings 5.00
3 Boiler make up 42.00
4 Cooling towers make up 57.25
5 Scrubbing system 4.00
6 Domestic 3.00
7 Gardening 5.00
Total 164.15
3.4.2 Power Requirement
Power requirement of proposed project will be made available through Telangana
State Southern Power Distribution Company Limited (TSSPDCL). The total power
requirement for the unit is 800 KVA respectively
D.G. sets of 250 KVA & 380 KVA is proposed installed to meet the emergency
power requirement of the plant.
3.4.3 Fuel Requirement
The company proposed to install 2 TPH & 5 TPH Coal Fired Boiler and total fuel
requirement of coal will be around 28.00 MT /Day and it will be procured from local
sources.
3.5 Quantity of wastes to be generated
3.5.1 Waste Water Generation and utilization
Total effluent generated in the project is 76.59 KLD. The treated water will be reused
for plant operations.
The HTDS waste water from Process after neutralization taken for treatment in
stripper followed by MEE and ATFD, vapor condensate collected and transferred to
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 11
Biological Treatment. LTDS waste water including domestic sewage, floor Washes,
Utilities waste water taken along with Vapour Condensate from MEE & ATFD for
Biological Treatment. Treated effluent from ETP sent to RO, RO permeate collected
and RO rejects are sent to MEE followed by ATFD for evaporation and separation of
salts. Evaporation salts collected and sent to TSDF. MEE & ATFD vapour
condensates collected & reused along with RO permeate in plant operations.
Table 3.4: Wastewater generation and Treatment Method
Unit HTDS KLD
LTDS KLD
Effluent Generation
in KLD
Treatment Method
Process 35.43 17.15 52.59 HTDS Effluent sent to stripper
followed by MEE/ATFD system.
LTDS effluents treated in ETP along
with MEE/ATFD vapour condensate.
Treated effluent is sent to RO, RO
permeate water is recycled and RO
rejects taken for evaporation in MEE
followed by ATFD to collect
evaporation salts for disposal to
TSDF, MEE Condensate collected
and reused along with RO permeate.
Washings 5.00 0.00 5.00 Boiler Blow down 0.00 6.00 6.00 Cooling towers Blow down
0.00 6.50 6.50
Scrubbing system 4.00 0.00 4.00
Domestic 0.00 2.50 2.50
Total 44.43 32.15 76.59
3.5.2 Solid waste generation and Disposal
The types of Hazardous and non Hazardous wastes generated from the project,
method of disposal is shown in below table 3.5.
Table 3.5: Solid / Hazardous waste generation and Disposal
S. No Name of the Solid/ Hazardous Wastes
Quantity
Disposal Method
1 Organic waste (Process Residue)
456.06 Kgs/Day Sent to Cement Industries
2 Spent Carbon 138.17 Kgs/Day Sent to Cement Industries 3 Solvent Distillation Residue 1247.86 Kgs/Day Sent to Cement Industries 4 Inorganic Waste 462.73 Kgs/Day Sent to TSDF 5 MEE Salts 1666.01 Kgs/Day Sent to TSDF 6 Organic Evaporative Liquid (
from MEE Stripper) 890 Kgs/Day Sent to Cement Industry
7 ETP Sludge 200 Kgs/Day Sent to TSDF
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 12
8 Used Oils 500 Ltrs/Annum
SPCB Authorized Agencies for Reprocessing/Recycling
9 Containers liners 300 No’s / Month
After Detoxification sent to outside agencies
10 Used Lead Acid Batteries 4 No’s/ Annum
Send back to suppliers for buyback of New Batteries
11 Ash from boiler 9800.00 Sent to Brick Manufacturers
3.6 Schematic representations of the feasibility drawing which give
information of EIA purpose.
The applicability of the S.O.1533 for the proposed project was explored by
considering different possibilities & provision made in the said notification.
Considering the products & project location of the proposed project it is noticed that
the proposed project falls under Category 5 (f) “A” of the Schedule-I of EIA
Notification S.O.1533.
As per the provision of the SO 1533, it is necessary to get Environmental Clearance
by applying to MoEF&CC along with the Environmental Impacts Assessment Study
Report for the proposed project prior to commissioning of the project activities.
Therefore the EIA is required to conduct to comply with provisions of SO 1533 made
for Category 5(f) “A” of schedule –I of the notification.
4.0Site Analysis
4.1 Connectivity
Vedgir Life Sciences located at Sy. No: Parts of 318, 319 and 321 Pallepahad
Village, Thurkapally Mandal, Yadadri - Bhongir district, Telangana State.
• The nearest habitation from the site is Pallepahad Village at a distance of 0.50
kms (NNW).
• The nearest railway station is Bhongir Railway Station at a distance of 11.50
kms (SSE) from the site.
• The nearest airport is Rajiv Gandhi International Airport at a distance of 58
kms
• The Nearest road ways State Highway No.17 – 1.90 kms
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 13
4.2 Land Form, Land use and Land ownership.
The land use of the Area of 9.77 Acres (39537.79 Sq.m) will be permanently
changed to industrial purpose.
4.3 Existing Infrastructure.
The Proposed project is a Greenfield project which is 1.90 kms away from SH-17
and Mandal head quarter Turkapally is 6.00 kms (NNE) from the project site.
4.4 Soil classification
The predominant soils in the district are Red sandy soil, Sandy Loam Soil and black
soil.
4.5 Climatic data from secondary sources.
Temperature Maximum: 44.5 oC
Minimum: 10.6 oC
Normal annual rainfall : 651.5 mm
4.6 Social Infrastructure available.
Well developed social infrastructure facilities are available at nearby Habitations.
5.0 Planning Brief
Proposed plant activities will be started after getting statutory clearance form related
authorities. The project will be completed within two years.
Further project management will take care of all the rules and regulation of statutory
authority and provide the control measure and devices to achieve the standard
norms
6.0 Proposed Infrastructure
6.1 Industrial Area
The infrastructure and other facilities are already well developed in Turkapally, which
is a Mandal head quarter.
6.2 Residential Area
The employees who will work in the industry are from nearby villages and hence no
proposal for residential area for employees.
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 14
6.3 Green Belt:
48.78 % of Green Belt will be developed and maintained.
6.4 Social Infrastructure:
Facilities like road and communication are good; Banks, ATM's and medical facilities
are also adequate.
Amenities:
Education- schools including middle, secondary and higher secondary schools,
social welfare hostels.
Medical and Health- Community Health Centre & Primary Health center are
available in Turkapally which is 6.50 kms NNE of proposed project site.
Power and water- All the villages are electrified and drinking water facilities are
extended to all villages.
Rail and Road- The project site is very well connected by road through State
Highway No. 17 and nearest railway station is Bhongir.
6.5 Water management
Water requirement will be met through ground water.
6.6 Sewerage System:
There will be no discharge of industrial effluent as company proposing Zero Liquid
Discharge (ZLD) system. The treated effluent will be reused.
6.7 Industrial Waste Management:
Due to proposed project, the effluent from cooling and Plant/Equipment washing will
be generated and treated in the well designed Effluent Treatment Plant. The treated
effluent will be reused.
7.0 Rehabilitation and Resettlement (R & R) Plan
Rehabilitation & Resettlement (R & R) plan is not applicable to this proposed project.
8.0 Project Schedule & Cost Estimates
Proposed project activities will be started after getting statutory clearance form
related authorities. The project will be completed within two years.
PRE FEASIBILITY REPORT
Vedgir Life Sciences Page 15
Proposed activity will provide benefits to the local people in terms of financial and
social welfare.
The project cost for proposed Project is 18.00 Crores will be used for constructing
additional building, Equipments & misc.
9.0 Analysis of proposal (Final Recommendations)
� Local people will get direct financial benefit by way of employment.
� Local people will get some contracts of supply and services to get indirect
income.
� Company will contribute in improving education and health facilities in nearby
area.